BXPHARMA logo

Beximco Pharmaceuticals PLC. Stock Price

DSE:BXPHARMA Community·৳45.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 48 Fair Values set on narratives written by author

BXPHARMA Share Price Performance

৳101.90
23.70 (30.31%)
৳101.90
23.70 (30.31%)
Price ৳101.90

BXPHARMA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

1 Risk
4 Rewards

Beximco Pharmaceuticals PLC. Key Details

৳46.3b

Revenue

৳25.8b

Cost of Revenue

৳20.6b

Gross Profit

৳14.2b

Other Expenses

৳6.4b

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
14.24
44.42%
13.71%
10.8%
View Full Analysis

About BXPHARMA

Founded
1976
Employees
1122
CEO
Iqbal Ahmed
WebsiteView website
www.beximcopharma.com

Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals PLC. was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Recent BXPHARMA News & Updates

Recent updates

No updates

Beximco Pharmaceuticals PLC. Competitors